Coherus Oncology (CHRS) Net Long-Term Debt Issued (Repaid) (2016 - 2024)
Coherus Oncology's Non-Current Debt came in at $37.25 million for Q2 2026, up 1.0% from $36.87 million a year earlier and up 0.3% from the prior quarter.
Coherus Oncology (CHRS) Net Long-Term Debt Issued (Repaid) (2016 - 2024) Analysis & Trends
At the end of FY2025, Coherus Oncology's Non-Current Debt was $37.05 million, up 1.0% from FY2024.
- Non-Current Debt carries a five-year compound annual growth rate of -13.0% (FY2020 to FY2025).
- Going back by year, Non-Current Debt was $36.7 million in FY2024 (-85.1%), $246.48 million in FY2023 (+0.4%), $245.48 million in FY2022 (+225.1%) and $75.51 million in FY2021 (+1.4%).
- The Q2 2026 figure represents the highest quarterly Non-Current Debt since Q1 2024.
- Year-over-year, Non-Current Debt has increased for five consecutive quarters, with an average decline of 26.8% over the last eight quarters.
- The fastest year-over-year change in Non-Current Debt over five years came in Q3 2022 (growth of 323.4%), and the weakest in Q2 2024 (a decline of 85.1%).
- Business Quant data shows CHRS's Non-Current Debt at $37.15 million (Q1 2026), $37.05 million (Q4 2025) and $36.96 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net LT Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.54 Bn | 1,195.15 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 650.21 Bn | 570.07 Bn | 17.30 Bn | -1.00 Mn |
| 3 | AbbVie | 508.24 Bn | 476.24 Bn | 13.12 Bn | 9.98 Bn |
| 4 | Merck | 360.07 Bn | 323.01 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 312.26 Bn | 285.49 Bn | - | - |
| 6 | Astrazeneca | 285.31 Bn | 259.20 Bn | 13.26 Bn | 4.91 Bn |
| 7 | Amgen | 247.74 Bn | 199.39 Bn | 7.58 Bn | -3.05 Bn |
| 8 | Gilead Sciences | 207.12 Bn | 182.22 Bn | 6.73 Bn | -19.00 Mn |
| 9 | Pfizer | 166.13 Bn | 113.48 Bn | 12.56 Bn | - |
| 10 | Coherus Oncology | 116.17 Mn | -519.97 Mn | 10.07 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -141,000.00 |
| Dec 31, 2022 | 81.75 Mn |
| Sep 30, 2022 | 49.49 Mn |
| Mar 31, 2022 | 440,000.00 |
| Mar 31, 2021 | 222.20 Mn |
| Sep 30, 2020 | -674,000.00 |
| Jun 30, 2020 | 222.83 Mn |
| Sep 30, 2019 | -106,000.00 |
| Jun 30, 2019 | 185,000.00 |
| Mar 31, 2019 | 72.88 Mn |
| Mar 31, 2016 | 100.00 Mn |
Coherus Oncology Net Long-Term Debt Issued (Repaid) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=CHRS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();